Downregulation of ENG plays a crucial role in RSVL-promoted tumor microvessel growth, which leads to increased blood perfusion and drug delivery into tumor, thereby resulting in an enhanced anticancer effect of GEM. The gene discussed is ENG; the disease is neoplasm.